High-performance liquid chromatographic analysis of idarubicin and fluorescent metabolites in biological fluids
- 1 January 1992
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 30 (4), 303-306
- https://doi.org/10.1007/bf00686300
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Method for the determination of 4-Demethoxydaunorubicin, its quinone and hydroquinone metabolites in human plasma and urine by high-performance liquid chromatographyCancer Chemotherapy and Pharmacology, 1987
- Clinical pharmacology of oral and intravenous 4-demethoxydaunorubicinCancer Chemotherapy and Pharmacology, 1987
- Pharmacokinetics of idarubicin (4‐demethoxydaunorubicin; IMI‐30; NSC 256439) following intravenous and oral administration in patients with advanced cancer.British Journal of Clinical Pharmacology, 1987
- Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)Cancer Chemotherapy and Pharmacology, 1986
- Low dose oral administration of 4-demethoxy-daunorubicin (idarubicin) in advanced cancer patientsCancer Chemotherapy and Pharmacology, 1986
- Idarubicin (4-demethoxydaunorubicin)Investigational New Drugs, 1986
- PHASE-I AND PHASE-II CLINICAL AND PHARMACOLOGICAL STUDY OF 4-DEMETHOXYDAUNORUBICIN (IDARUBICIN) IN ADULT PATIENTS WITH ACUTE-LEUKEMIA1985
- PHASE-I AND CLINICAL-PHARMACOLOGY STUDIES OF INTRAVENOUS AND ORAL-ADMINISTRATION OF 4-DEMETHOXYDAUNORUBICIN IN PATIENTS WITH ADVANCED CANCER1983
- High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivativeJournal of Chromatography B: Biomedical Sciences and Applications, 1983